Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02545868 |
|---|---|
| Brief Title: | A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis |
| First Submitted : | September 8, 2015 |
| First Submitted that Met QC Criteria : | September 8, 2015 |
| First Posted : | September 10, 2015 (Estimate) |
| Results First Submitted : | February 13, 2018 |
| Results First Submitted that Met QC Criteria : | May 2, 2018 |
| Results First Posted : | June 6, 2018 |
| Last Update Submitted that Met QC Criteria : | April 4, 2022 |
| Last Update Posted : | April 28, 2022 |